Intestinal cancer progression by mutant p53 through the acquisition of invasiveness associated with complex glandular formation

Tumor suppressor TP53 is frequently mutated in colorectal cancer (CRC), and most mutations are missense type. Although gain-of-functions by mutant p53 have been demonstrated experimentally, the precise mechanism for malignant progression in in vivo tumors remains unsolved. We generated Apc(Δ716) Trp...

Cijeli opis

Spremljeno u:
Bibliografski detalji
Izdano u:Oncogene
Glavni autori: Nakayama, M, Sakai, E, Echizen, K, Yamada, Y, Oshima, H, Han, T-S, Ohki, R, Fujii, S, Ochiai, A, Robine, S, Voon, D C, Tanaka, T, Taketo, M M, Oshima, M
Format: Artigo
Jezik:Inglês
Izdano: Nature Publishing Group 2017
Teme:
Original Article
Online pristup:https://ncbi.nlm.nih.gov/pmc/articles/PMC5658682/
https://ncbi.nlm.nih.gov/pubmed/28628120
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/onc.2017.194
Oznake: Dodaj oznaku
Bez oznaka, Budi prvi tko označuje ovaj zapis!

Similar Items